Blessed were the "cheap" and the loss-makers (or what ASX stocks did in the August earnings season)
Our analysis indicates that August was a month of extremes on the ASX with a renewed focus on price at one end of the spectrum but also a strong element of speculation at the other. This is probably a good environment for micro caps - some of whom have been lowly priced compared to metrics for larger businesses in their sectors; and others that are at an early stage and require "animal spirits" to drive their share prices.
The big guns on the ASX, as measured by the S&P/ASX 100, pushed through for a 1.9% gain in August, against a backdrop of dividend cuts and with considerable correlation for many of these large businesses with the weak domestic economy. The S&P/ASX Small Industrials was up 9.5%. Our Dragonfly Fund, which is heavily weighted to micro caps, looks like it had its best ever single month return (for the second consecutive month) - but we're still finalising the figures.
2.5 stocks up for every one that declined
We track a pool of over 600 ASX-listed companies that had market caps of less than $5 billion at the start of the year and were revenue generative. Our “FIT” (Financials, Industrials & Technology) universe measures the share price performance of companies that meet the following criteria:
- ASX-listed;
- Market caps of between $10 million and $5 billion;
- At least $5m annual revenue in the previous financial year; and
- Not a mining or energy resource company.
For this group of stocks we found that in August 2020:
- The median share price gain was +7%; and
- ~ 2.5 stocks increased for every stock that decreased.
Share price moves need to be used as a proxy for the impact of earnings results released in August given the majority of these smaller companies do not have analyst coverage - so we can't review the announced results relative to consensus forecasts and we can't consider analysts' earnings revisions. But undoubtedly the share price moves also reflect changes in overall market sentiment.
For the minority of companies in this universe that do have analyst coverage, there were slightly more downgrades than upgrades to both revenue and EPS expectations - but it was pretty evenly balanced.
Refocus on price